FDAFDA · Food and drugs·Recall number D-0094-2026
NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
Published October 15, 2025 · Recall initiated: July 30, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Sterile Products: elevated endotoxin levels
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- GenoGenix LLC
- Distributor
- US Nationwide.
- Lot
- Lot#: GG121624-023, within expiry
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.